is a powerful psychoactive cannabinoid with an intoxicating effect many times stronger than
More information on the substance may be found on
Legal situation in Austria
THCP and its derived substances (d8-THCP, THCP-O, etc.) are subject to Austria’s New Psychotropic Substances Act
. This means that the production and/or trade of THCP products is prohibited. THCP products may be confiscated by
authorities. Possession and consumption are exempt from punishment.
Legal situation in Germany
The BtMG does not explicitly mention THCP. As of October 2023, possession and consumption of THCP products is not
prohibited in Germany. Whether THCP falls under the German New Psychoactive Substances Act (NpSG) is still being
determined. We assume that the trade with THCP products for utilisation (consumption, vaping, smoking) is most
likely prohibited. The expected penalty is unclear. This depends on which and how many laws have been violated.
These may include: Food Safety and Consumer Protection Act (LMSVG), New Psychoactive Substances Act (NpSG),
Medicines Act (AMG), and, in the case of smokable products, the Tobacco Act and Non-Smoker Protection Act.
Legal situation in Europe
In the countries that have a New Psychoactive Substances Act (NpSG) in which group definitions according to
structures are laid down (Austria, Germany, Poland, France, etc.), THCP is subject to this NPSG or further
clarifications may be expected. We may assume that the entire EU area will adopt a uniform regulation sooner or
THCP is detectable in body fluids with the usual drug tests. Blood tests in the context of driver fitness
examinations are able to identify THCP as a psychotropic substance. In urine drug tests for proof of abstinence,
THCP can be detected with the most common THC tests. In the next few years, studies will determine detection times
. Until then, THCP detection times may be assumed to be similar to THC.
The THCP in sales products is not a natural product, it is always produced synthetically. Natural THCP occurs far
too rarely and in far too low concentrations (between 0.0023% to 0.0136%) to be used commercially.
The production of THCP primarily results in by-products. Most THCP products sent to our laboratory did contain
unknown by-products or THC.
THCP behaves as a full agonist to the CB1 receptor. This means potent and long-lasting effects may occur
unexpectedly, even at lower doses. There is currently no study data on the toxicity, neurotoxicity, or
carcinogenicity of THCP or its by-products. Therefore, we do not know whether THCP products damage organs or
nerves or cause cancer.
If someone is harmed by consuming a THCP product, the producer and/or seller can be held responsible as competent
§ 88 StGB
(Austrian Criminal Code, negligent physical injury).
We at the IFHA see our role as supporting companies in improving the
quality, product, and consumer safety of hemp and hemp products. Therefore, we recommend not to consume or trade
with THCP products. In our Cannabis Advanced Analysis, we can detect the presence of THCP and assess whether a
sample is THCP free.